PlainRecalls
FDA Drug Low Class III Terminated

Donepezil Hydrochloride Tablets, 10 mg, packaged in a) 30-count bottles (NDC 0781-5275-31) and b) 1000-count bottles (NDC 0781-5275-10), Rx only, Manufactured in India by Sandoz Private Ltd for Sandoz Inc., Princeton, NJ 08540.

Reported: January 25, 2017 Initiated: December 13, 2016 #D-0435-2017

Product Description

Donepezil Hydrochloride Tablets, 10 mg, packaged in a) 30-count bottles (NDC 0781-5275-31) and b) 1000-count bottles (NDC 0781-5275-10), Rx only, Manufactured in India by Sandoz Private Ltd for Sandoz Inc., Princeton, NJ 08540.

Reason for Recall

Subpotent Drug: out of specification results for assay test.

Details

Recalling Firm
Sandoz Inc
Units Affected
a) 10,200 bottles; b) 300 bottles
Distribution
Nationwide in the USA
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Donepezil Hydrochloride Tablets, 10 mg, packaged in a) 30-count bottles (NDC 0781-5275-31) and b) 1000-count bottles (NDC 0781-5275-10), Rx only, Manufactured in India by Sandoz Private Ltd for Sandoz Inc., Princeton, NJ 08540.. Recalled by Sandoz Inc. Units affected: a) 10,200 bottles; b) 300 bottles.
Why was this product recalled?
Subpotent Drug: out of specification results for assay test.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 25, 2017. Severity: Low. Recall number: D-0435-2017.